NDC 62157-864-01 - Erythromycin Ethylsuccinate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62157-864
- Requested NDC
- 62157-864-01
- Package NDCs from labels
- 62157-864-01
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2019-06-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Erythromycin Ethylsuccinate - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2019-06-14 | BULK INGREDIENT |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| E.E.S 400 | ERYTHROMYCIN ETHYLSUCCINATE | REMEDYREPACK INC. | 49b3ca93-43cc-439c-8f5d-e3ea2e87ad2f | 2026-06-23 | Warnings, Adverse reactions | 1014KSJ86F |
| Erythromycin ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | Bryant Ranch Prepack | 78139f33-0965-4bbb-a53f-6d7fd4fa9a81 | 2026-06-05 | Warnings, Adverse reactions | 1014KSJ86F |
| Erythromycin ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | Bryant Ranch Prepack | 1d9eb7cb-0b11-4f6e-8a9c-1bcff37fe0b5 | 2026-06-05 | Warnings, Adverse reactions | 1014KSJ86F |
| Erythromycin ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | Kanchan Healthcare Inc | a7f7faaf-dc05-4d51-86c6-bf5d61562e48 | 2026-04-08 | Warnings, Adverse reactions | 1014KSJ86F |
| Erythromycin Ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | ANI Pharmaceuticals, Inc. | 3d80f96e-3bbe-4fa5-89a8-694c61dd5e8f | 2025-06-20 | Warnings, Adverse reactions | 1014KSJ86F |
| Erythromycin Ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | ANI Pharmaceuticals, Inc. | 3de1e0b9-473b-44c0-a644-5fa14ad69a83 | 2025-06-20 | Warnings, Adverse reactions | 1014KSJ86F |
| Erythromycin Ethylsuccinate | ERYTHROMYCIN | Amneal Pharmaceuticals NY LLC | 581d7430-1a80-42a6-befb-4c3ae8140392 | 2025-04-25 | Warnings, Adverse reactions | 1014KSJ86F |
| Erythromycin Ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | Nivagen Pharmaceuticals, Inc. | 46f74c4f-10fc-44cf-aec4-d113f49149bc | 2024-01-02 | Warnings, Adverse reactions | 1014KSJ86F |
| Erythromycin Ethylsuccinate | ERYTHROMYCIN | Amneal Pharmaceuticals NY LLC | 596fa019-b0eb-4e57-93ff-195a765a2e91 | 2023-12-29 | Warnings, Adverse reactions | 1014KSJ86F |
| E.E.S 400 | ERYTHROMYCIN ETHYLSUCCINATE | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | b455bbdb-a3f1-470f-aa5f-ed83ac2e228d | 2023-12-16 | Warnings, Adverse reactions | 1014KSJ86F |
| Ery-Ped | ERYTHROMYCIN ETHYLSUCCINATE | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | 04775721-ab87-4b66-808c-d67a21032385 | 2023-12-16 | Warnings, Adverse reactions | 1014KSJ86F |
| ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | 23a0564e-dca9-41bc-b2c7-0461169f65f9 | 2023-12-16 | Warnings, Adverse reactions | 1014KSJ86F |
| Erythromycin ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | Cadila Pharmaceuticals Limited | db70798e-5e07-41d6-afe9-82c272bc5cc0 | 2023-11-11 | Warnings, Adverse reactions | 1014KSJ86F |
| ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | Wilshire Pharmaceuticals | 86d6353c-2b58-4219-b31d-fb5b97789094 | 2020-09-24 | Warnings, Adverse reactions | 1014KSJ86F |
| Erythromycin Ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | Wilshire Pharmaceuticals Inc. | f4a3fffd-ce02-450f-bbcc-d425374e3e32 | 2019-01-29 | Warnings, Adverse reactions | 1014KSJ86F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.